References
- Narrow WE, Rae DS, Robins LN, et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002; 59(2): 115–23
- Pincus HA, Pettit AR. The societal costs of chronic major depression. J Clin Psychiatry 2001; 62(Suppl 6): 5–9
- Mental health: a report of the surgeon general. US Dept of Health and Human Services, Public Health Service, 1999. Available at: http://www.surgeongeneral.gov/library/mentalhealth/home.html. Accessed May 8, 2002
- Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002; 287(2): 203–9
- American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157(Suppl 4): 1–45
- Sasich LD, Torrey EF, Wolfe SM, for the Public Citizen's Health Research Group. Report on the international comparison of prices of antidepressant and antipsychotic drugs (HRG publication No. 1446). Available at: http://www.citizen.org/publications/release.cfm?ID=6642. Accessed May 8, 2002
- Karki SD, Patterson WR, Masoon G-R. Usage patterns of antidepressant medications in a community nursing home. Ann Long-Term Care 1999; 7(10): 364–8
- The Lewin Group. Access and utilization of new antidepressant and antipsychotic medications. US Dept of Health and Human Services. Available at: http://aspe.os.dhhs.gov/health/reports/psychmedaccess. Accessed May 8, 2002
- South Carolina Department of Mental Health. Prescription drug patient assistance programs. Available at: http://www.state.sc.us/dmh/clinical/medication.htm#med5. Accessed May 8, 2002
- Sonawalla SB, Spillmann MK, Kolsky AR, et al. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders. J Clin Psychiatry 1999; 60(9): 580–3
- Delgado PL, McGahuey CA, Moreno FA, et al. Treatment strategies for depression and sexual dysfunction. J Clin Psychiatry Monograph 1999; 17(1): 15–21
- Nurnberg HG, Gelenberg A, Hargreave TB, et al. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001; 158(11): 1926–8
- Clayton AH, McGarvey EL, Abouesh AI, et al. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry 2001; 62(3): 185–90
- Cadieux RJ. Antidepressant drug interactions in the elderly: understanding the P-450 system is half the battle in reducing risks. Postgrad Med 1999; 106(6): 231–49
- Nemeroff CB, De Vane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153(3): 311–20
- Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression—an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313(7052): 253–8
- Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA 2001; 285(15): 1978–86
- Parker V, Wong AH, Boon HS, et al. Adverse reactions to St John's Wort. Can J Psychiatry 2001; 46(1): 77–9